China Cord Blood Corp. (CO) Reports Q4 EPS of RMB0.46

China Cord Blood Corp. (NYSE: CO) reported Q4 EPS of RMB0.46, versus RMB0.32 reported last year. Revenue for the quarter came in at RMB151.9 million, versus RMB133 million reported last year.

New subscriber sign-ups and accumulated subscriber base reached 17,136 and 376,623, respectively.

For earnings history and earnings-related data on China Cord Blood Corp. (CO) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
• Bernstein SocGen on Intuitive Surgical (ISRG): 'We see $400 as a great entry point'